8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements

Elevance Health ($ELV) filed an 8‑K on Jan 28, 2026 furnishing a press release (Exhibit 99.1) with…

Filed with the SEC on January 28, 2026 · Summarized by InvestorsBot

Elevance Health ($ELV) filed an 8‑K on Jan 28, 2026 furnishing a press release (Exhibit 99.1) with financial results for the quarter ended Dec 31, 2025; Inline XBRL cover page included as Exhibit 104. 📄📊 #8K #Earnings #Healthcare

The 8‑K includes standard forward‑looking statements/risks language; the report is signed Jan 28, 2026 by Kathleen S. Kiefer, Chief Governance Officer & Corporate Secretary. ⚠️ $ELV #Regulatory #Disclosures

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from Elevance Health, Inc.

Elevance Health ($ELV) reafﬁrms FY2026 adjusted shareholders’ earnings ≥ $25.50/share and 2026 benefit…

8-K · March 10, 2026

Feb 27, 2026: CMS notified Elevance Health ($ELV) of intent to impose intermediate sanctions — suspend…

8-K · March 2, 2026

Elevance Health ($ELV) filed an 8‑K on Feb 26, 2026 furnishing a press release (Exhibit 99.1) and the…

8-K · February 26, 2026

Elevance Health ($ELV) reaffirms FY2026 EPS guidance: ≥ $22.30 diluted (includes ~ $3.20 of net…

8-K · February 26, 2026

Elevance Health ($ELV) announced Feb 26, 2026 that Peter D.

8-K · February 26, 2026

Elevance Health ($ELV) on Jan 28, 2026 issued a press release reporting Q4 & full‑year 2025 financial…

8-K · January 28, 2026